Rhabdomyosarcoma of the orbit in a four months old infant in Zimbabwe: A case report

I Chitsike1, R Masanganise, D Sibanda

  • 1Department of Paediatrics and Child Health, University of Zimbabwe, College of Health Sciences, P.O. Box A 178, Avondale, Harare, Zimbabwe.

The Central African Journal of Medicine
|August 11, 2015
PubMed

Insights

Infants with rhabdomyosarcoma have a poorer prognosis due to local failure. Aggressive treatment and optimal chemotherapy are crucial for better outcomes in infant rhabdomyosarcoma.

Area of Science:

  • Pediatric Oncology
  • Cancer Research

Background:

  • Rhabdomyosarcoma presents a significant challenge in infants, often associated with poorer prognoses compared to older children.
  • High rates of local failure contribute to adverse outcomes in infant rhabdomyosarcoma cases.

Observation:

  • This report details a 4-month-old infant diagnosed with orbital rhabdomyosarcoma, experiencing a poor outcome.
  • The case highlights challenges in managing infant rhabdomyosarcoma, including reluctance towards aggressive local control and suboptimal chemotherapy.

Findings:

  • Infants with rhabdomyosarcoma face worse prognoses, largely due to difficulties in achieving local disease control.
  • Suboptimal chemotherapy dosing and hesitation in employing aggressive local therapies are identified as key factors impacting infant outcomes.

Implications:

  • Further research is essential to establish effective and appropriate local therapeutic strategies for infants diagnosed with rhabdomyosarcoma.
  • Optimizing chemotherapy regimens and local control measures are critical for improving survival rates in this vulnerable population.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...